irinotecan,leucovorin,oxaliplatin,nab-paclitaxel,gemcitabine
Ipsen
[]
the napoli 3 study, presented by dr. zev wainberg, meets its primary endpoint of improved os for nalirifox vs. gem-abrax in 1l metastatic pancreatic cancer. #gi23 
MD/PhD Heme/Onc fellow @WUSTL
GI cancers || single-cell genomics
Proud dad, fish keeper, language learner
https://t.co/m7AbNIgWB4 || https://t.co/4Nu6wdD8o7